Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
The Case For Hims & Hers: Diversification And Growth Beyond Semaglutide
06:11am, Tuesday, 25'th Mar 2025
Hims & Hers has risen 70% since November 2024, outperforming the S&P 500, despite recent regulatory challenges impacting its compounded semaglutide product. Its diversified portfolio in men's and wome
Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?
09:05am, Monday, 24'th Mar 2025
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price i
Hims & Hers Health: Developing A Better Understanding
04:38pm, Thursday, 20'th Mar 2025
Hims & Hers Health has become one of the most popular growth stocks in the market today. After sharing with my readers a bullish perspective on the stock at ~$6/share in 2023, I'm back to provide a un
Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy
01:40pm, Thursday, 20'th Mar 2025
Hims & Hers Health, Inc. stock surged to $68, and the subsequent 50% crash is the talk of the town. I'm eyeing it as a favorable high-risk, high-reward play. HIMS stock plummeted after the FDA halted
Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
11:35am, Thursday, 20'th Mar 2025
Hims & Hers (HIMS) is a newfangled tele-health company that started to ride the waves of GLP-1 weight loss medications. As waves go, this one's given the stock a heck of ride; way up and then all the
Why Hims & Hers Stock Tumbled on Tuesday
11:40am, Tuesday, 18'th Mar 2025
Hims & Hers Health (HIMS -6.95%) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target on the pharmaceuticals stock in the worst way possible.
Why Hims & Hers Stock Popped on Monday
12:12pm, Monday, 17'th Mar 2025
Hims & Hers Health (HIMS 3.58%) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach delivered some good news for the mail-order drugs stock.
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
01:00am, Thursday, 13'th Mar 2025
MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged single-stock ETFs designed to provide amplified exposure to Rocket Lab USA, Inc. (NASDAQ: RKLB) and H
Why the Market Dipped But Hims & Hers Health, Inc. (HIMS) Gained Today
06:50pm, Tuesday, 11'th Mar 2025
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $34.71, marking a +0.7% move from the previous day.
Why Hims & Hers Health Stock Just Popped
11:19am, Tuesday, 11'th Mar 2025
Roller-coaster healthcare stock Hims & Hers Health (HIMS 5.26%), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Ad
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:05am, Tuesday, 11'th Mar 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Buy Hims & Hers Stock on the Dip?
07:00am, Tuesday, 11'th Mar 2025
Hims & Hers (HIMS -4.12%) is taking investors on a roller-coaster ride in 2025.
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
05:30am, Tuesday, 11'th Mar 2025
Hims & Hers (HIMS -4.12%) stock is down 50% from its peak earlier this year, but the drop in shares hasn't been driven by deteriorating operations. In fact, the company is growing as fast as ever.
3 Cold Stocks That Can Bounce Back This Week
10:15am, Monday, 10'th Mar 2025
This past week was rough for most investors, but it was a lot harder for a handful of cascading stocks. There were nearly a dozen U.S. exchange-listed companies with market caps north of $1 billion th
Bet on DuPont Analysis & Pick 5 Quality Stocks
07:36am, Monday, 10'th Mar 2025
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Hims & Hers Health (HIMS), Blue Bird (BLBD), EMCOR Group (EME), EverQuote (EVER) and Sprouts Farmers Market (SFM).
